Doribax regulatory update

EMA's CHMP recommended updating the label for Doribax doripenem to include higher dosage of the antibiotic in patients with nosocomial pneumonia, including ventilator-associated pneumonia (VAP). Specifically, CHMP recommended physicians

Read the full 294 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE